Event
Better.Be.First.
Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

NEWS

ARENSIA Innovation Workshop, September 28th, Düsseldorf, Germany ARENSIA Innovation Workshop, September 28th, Düsseldorf, Germany 28.09.2018

After last year´s success, we take pleasure to inform you that ARENSIA is organizing the 2nd Workshop focused on “Practical Insights and future visions to maximize efficiency in PROOF OF CONCEPT patient trials”. Industry leaders ...

ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA 16.05.2018

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on 16th May 2018 in San Francisco, CA. In today'...

ARENSIA Spotlight Session, November 07th, Boston, MA ARENSIA Spotlight Session, November 07th, Boston, MA 07.11.2017

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 7th November 2017 in Boston, MA. In today's fast-changing world, ...

ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine 03.08.2017

As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in patients, as of August 2017, ARENSIA expands its operations with a new clinical research unit in Kiev, Ukraine. Ukraine (45 Mio. ...

ARENSIA Spotlight Session, May 24th, San Francisco, CA ARENSIA Spotlight Session, May 24th, San Francisco, CA 24.05.2017

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 24th May 2017 in San Francisco, CA. In today's fast-changing worl...

2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann 2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann 04.01.2017

At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sop...

New Phase I Unit for pediatrics studies, Bucharest, Romania New Phase I Unit for pediatrics studies, Bucharest, Romania 10.11.2015

As of August 2015, ARENSIA expands its operations with a new clinical research unit in Bucharest, Romania. This unit is fully dedicated to exploratory clinical trials Phase 1 and 2 in PEDIATRIC patients (age 0-18) with chronic and acute conditions...